DEBUG INFO [ON] Page template: HIVnetChild_menu_nosidebar.php Search terms :
Since its inception in 1990, the CTN has built a world-class national infrastructure that ensures Canadian HIV researchers collaborate locally and internationally to improve health outcomes, train the next generation of postdoctoral fellows, and lead cutting edge patient-oriented research in HIV and related conditions.
At the heart of the CTN is the National Centre, based in Vancouver. This site facilitates and supports research across Canada by efficiently centralizing administrative, methodological and management services, including communications and knowledge translation.
The Cores are responsible for managing the flow of concept development to protocols, supervising ongoing studies and mentoring junior investigators. In addition to reaching out to colleagues and sites across Canada, all four Cores are committed to working in partnership with individuals and clinical trial networks globally.
The CTN facilitates HIV trials and research studies through a network of 38 research clinics and hospitals. The National Centre provides clinical research services (for example, data management and statistical consultation) and a limited amount of funding to studies that are reviewed by the CTN review committees and then approved by the CTN Steering Committee. Details about study performance and enrolment are reported to the National Directors, Chief Administrative Officer, and the Chief Clinical Research Officer. The CTN funder, the Canadian Institutes of Health Research, requires annual performance reporting of this information from the National Centre.
CTN committees meet to review protocols, monitor trials in progress, set priorities and debate policy. They also advise the Steering Committee ensuring that all trials maintain the highest scientific and ethical standards. In addition to its standing committees, the CTN has a number of ad hoc committees and working groups on topics such as ethics review, postdoctoral fellowships, international research, and cohort studies.
CTN Postdoctoral Fellow Dr. Malika Sharma writes about the current state of PrEP in Canada and how CTN 303 looks to change the way these HIV prevention drugs are delivered.
Hi everyone! My name is Sonia, and I’m one of the Communications and Knowledge Translation Interns working with the CTN this summer.
Read the full text of Dr. Klein’s speech below. Tribute to Mark Wainberg It’s with great sadness that I stand…
The Resource includes sections about when to begin to include community, who to engage in the process, and how to develop roles and compensate team members.
2014 © CIHR Canadian HIV Trials Network
